The Michael Klag Lab focuses on the epidemiology and prevention of kidney disease, cardiovascular disease and hypertension. Our research determined that the U.S. was experiencing an epidemic of end-stage kidney disease, pinpointed the incidence of kidney disease and published scholarship on risk factors for kidney disease such as race, diabetes and socioeconomic status. Our Precursors Study has shown that serum cholesterol measured at age 22 years is a predictor for midlife cardiovascular disease, a finding that has influenced policy about cholesterol screening in young adults. We also research health behaviors that lead to hypertension and study how differences in these behaviors affect urban and non-urban populations.

Our research program focuses on projects that seek to understand and optimize daily function, quality of life and health equity for individuals with multiple sclerosis (MS) and related conditions, as well as their families, caregivers and support networks. Our projects include research on cognitive function (e.g., thinking, memory), emotional function (e.g., mood and stress), health behaviors (e.g., self-management of sleep, fatigue, physical activity) and social determinants of health (e.g., healthcare access, socioeconomic status, employment) that affect quality of life in MS.